India – Local pharmaceutical company Lupin has acquired five brands under the Italian pharmaceutical company Menarini. The brands include Piclin, Menoctyl, Sucramal O, Pyridium, and Distaclor. These legacy brands will help Lupin in further enhancing its diverse portfolio and solidifying its position as a leading pharmaceutical organisation in India.
Lupin has been exclusively marketing these brands in the Indian market since July 2021 under a distribution and promotion agreement with A. Menarini India Private Limited. This strategic acquisition for the Indian market marks a significant step forward for Lupin as it continues to expand its presence in India.
Nilesh Gupta, managing director at Lupin, said, “This acquisition aligns well with our strategic goal to broaden our presence in the Indian market. By offering a comprehensive range of products, our aim is to deliver even greater value to our stakeholders and the communities we serve.”
Meanwhile, Girisan Kariangal, managing director at Menarini India, commented, “Lupin has been successfully marketing the scope brands for Menarini since 2021, which has been a testament to our evolved collaboration. I am happy that Lupin will now carry forward their legacy with full trademark ownership.”
He added, “For Menarini, this transaction further signals our continued commitment to nurture and expand our Dermatology and Aesthetics portfolio and business. Menarini is a top 10 multi-national company in this therapeutic area in India and has witnessed strong organic and inorganic growth.”
